Navigation Links
New Non-Surgical Stem-Cell Procedure Relieves Degenerative Joint Disease
Date:11/8/2007

First-of-its-kind procedure from Colorado-based company

DENVER, Nov. 8 /PRNewswire/ -- Regenerative Sciences, Inc., has launched its patent-pending Regenexx(TM) procedure, which uses a patient's own stem cells to regenerate bone and cartilage -- a welcome relief for the more than 20 million Americans who suffer from painful and debilitating orthopedic conditions.

"The Regenexx procedure is different from all other treatments available today," said Chris Centeno, M.D., creator of Regenexx and an international expert and specialist in musculoskeletal, spinal and neurological injury. "Prior to Regenexx, physicians were limited in what they could offer degenerative joint patients: surgery or life with pain. Now physicians have a new tool in their tool kit."

In sanctioned clinical trials, Regenexx has been demonstrated to be safe and regenerates normal healthy tissues. A patient's stem cells are extracted with a needle from the hip, grown in culture at a Rengerative Sciences lab and then re-implanted into the patient at a doctor's office with a "needle out, needle in" approach, which substantially reduces downtime for the patient.

Unlike joint replacement or micro fracture that require weeks or months of being on crutches and pain medicines, the Regenexx procedure has no downtime. Most patients return to normal activity within 24 hours of completing the procedure.

A published clinical trial was conducted with a 46-year-old woman who had a two-year history of knee pain that began after being kicked in the shin during a martial arts class. Bone marrow was drawn from the patient, and in the next nine days, the marrow was used to grow mesenchymal stem cells, which have the ability to grow into bone, cartilage and muscle tissues. The grown stem cells initially taken from the patient were injected into her knee once a week for the next three weeks. Three months after the procedure, the patient reported that her pain had essentially disappeared. A MRI confirmed that the defect on her femur had been reduced by one-third.

Repair of the degenerated or injured area usually takes place in two to three months, and many patients feel better in one to three months.

About Regenerative Sciences

Founded in 2006, Regenerative Sciences is the Denver-based developer of Regenexx(TM), a breakthrough non-surgical option for people suffering from various orthopedic disorders. Regenexx is a patent-pending procedure that uses a person's own stem cells and blood growth factors to regenerate bone and cartilage.

The physicians at Regenerative Sciences are dedicated to providing the option of non-surgical joint repair to their patients. Headquartered in Colorado, they focus on delivering high quality treatment for people suffering from these often debilitating diseases. Visit http://www.Regenexx.com to learn more about benefits, research and the Regenexx procedure.


'/>"/>
SOURCE Regenerative Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Prominent Farmington Plastic Surgeon Uses Two New Non-Surgical Procedures to Tighten Skin and Remove Fat
2. Newly Published Study in Leading Medical Journal Further Confirms the Brava Systems Non-Surgical Breast Enhancement Effectiveness
3. UK junior doctors gaining less experience of common procedures
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Eligard(R) six-month formulation successfully completes European approval procedure
6. Smoking can harm the long-term effects of some oral surgery procedures
7. Photo: Kyphon and the X-STOP(R) IPD(R) Procedure to be Featured on American Health Radio on Monday, September 24, 2007
8. Study Shows Cosmetic Surgery on the Rise as Safety and Efficacy of Procedures Increase
9. New Device for Clearing Blocked Arteries in the Legs Receives FDA Clearance for Peripheral Use - Procedures Performed Across the US Within First 48 Hours
10. Orthopedic Development Corporations TruFUSE(R) Procedure Tops 1,750 Patients in First Year
11. Decrease in the use of radiotherapy procedures for the treatment of cancer in hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... ... , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to ... unique items from across the nation, this holiday-themed event will raise funds and awareness ... VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Planet Fitness, ... the U.S., announced today its plans to open a flagship location in Covington, LA ... the former Rooms To Go store next to Office Depot in the Holiday Square ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:10/2/2017)... 2, 2017 Halo Labs announces the European launch of ... the HORIZON at MIBio 2017 in Cambridge, U.K ... particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity while ... technique Backgrounded Membrane Imaging. ... HORIZON subvisible particle analysis system ...
(Date:9/28/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will ... and webcast on Friday, November 3, 2017, beginning at ... at approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... financial performance and guidance for 2018, Hill-Rom executives will ... operational performance, and long-range financial outlook through 2020. ...
Breaking Medicine Technology: